4.7 Article

Diadenosine pentaphosphate is a potent activator of cardiac ryanodine receptors revealing a novel high-affinity binding site for adenine nucleotides

Journal

BRITISH JOURNAL OF PHARMACOLOGY
Volume 156, Issue 5, Pages 857-867

Publisher

WILEY
DOI: 10.1111/j.1476-5381.2008.00071.x

Keywords

ryanodine receptor; sarcoplasmic reticulum; ATP; diadenosine polyphosphates; Ca2+-release; cardiac

Funding

  1. British Heart Foundation

Ask authors/readers for more resources

Background and purpose: Diadenosine polyphosphates are normally present in cells at low levels, but significant increases in concentrations can occur during cellular stress. The aim of this study was to investigate the effects of diadenosine pentaphosphate (Ap5A) and an oxidized analogue, oAp5A on the gating of sheep cardiac ryanodine receptors (RyR2). Experimental approach: RyR2 channel function was monitored after incorporation into planar bilayers under voltage-clamp conditions. Key results: With 10 mu mol.L-1 cytosolic Ca2+, a significant 'hump' or plateau at the base of the dose-response relationship to Ap5A was revealed. Open probability (Po) was significantly increased to a plateau of approximately 0.2 in the concentration range 100 pmol.L-1-10 mu mol.L-1. High Po values were observed at > 10 mu mol.L-1 Ap5A, and Po values close to 1 could be achieved. Nanomolar levels of ATP and adenosine also revealed a hump at the base of the dose-response relationships, although GTP did not activate at any concentration, indicating a common, high-affinity binding site on RyR2 for adenine-based compounds. The oxidized analogue, oAp5A, did not significantly activate RyR2 via the high-affinity binding site; however, it could fully open the channel with an EC50 of 16 mu mol.L-1 (Ap5A EC50 = 140 mu mol.L-1). Perfusion experiments suggest that oAp5A and Ap5A dissociate slowly from their binding sites on RyR2. Conclusions and implications: The ability of Ap5A compounds to increase Po even in the presence of ATP and their slow dissociation from the channel may enable these compounds to act as physiological regulators of RyR2, particularly under conditions of cellular stress.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available